Latest Facility Acquisition News

Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.

Black Cat Syndicate reported a 33% jump in gold production for the June quarter, driven by ramped-up operations and strategic acquisitions, with even stronger growth forecast for September despite scheduled maintenance.

The Calmer Co. International Limited has secured a $2.64 million FJD loan from Fiji Development Bank to acquire a key Navua facility, marking a strategic step to bolster its kava processing and staff infrastructure.